Camilla Hofström

433 total citations
16 papers, 350 citations indexed

About

Camilla Hofström is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Camilla Hofström has authored 16 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Molecular Biology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Camilla Hofström's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Camilla Hofström is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Camilla Hofström collaborates with scholars based in Sweden, Iran and United States. Camilla Hofström's co-authors include Vladimir Tolmachev, Anna Orlova, Torbjörn Gräslund, Mohamed Altai, Mattias Sandström, Jennie Malmberg, Seyed Jalal Hosseinimehr, Lars Abrahmsén, Joanna Strand and Hadis Honarvar and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Scientific Reports.

In The Last Decade

Camilla Hofström

15 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Camilla Hofström Sweden 9 274 165 124 33 28 16 350
Veronica Bonasera Italy 5 66 0.2× 228 1.4× 152 1.2× 73 2.2× 11 0.4× 5 375
Elmer Santos United States 6 81 0.3× 105 0.6× 99 0.8× 53 1.6× 78 2.8× 8 283
Yuan Weng China 9 106 0.4× 101 0.6× 175 1.4× 63 1.9× 6 0.2× 25 360
Yung-Hua Wang United States 9 102 0.4× 116 0.7× 90 0.7× 60 1.8× 3 0.1× 18 282
Joshua Donaldson United States 7 102 0.4× 97 0.6× 153 1.2× 32 1.0× 2 0.1× 11 263
Martine Bocchini Italy 7 78 0.3× 110 0.7× 60 0.5× 167 5.1× 6 0.2× 13 318
Ryan Robb United States 7 25 0.1× 105 0.6× 144 1.2× 43 1.3× 18 0.6× 18 282
Elza de Bruin United Kingdom 7 53 0.2× 87 0.5× 64 0.5× 43 1.3× 13 0.5× 11 195
Nicole D. Nicholas United States 3 232 0.8× 243 1.5× 104 0.8× 23 0.7× 2 0.1× 3 328
Grete Hasvold Norway 9 69 0.3× 101 0.6× 193 1.6× 34 1.0× 8 0.3× 13 348

Countries citing papers authored by Camilla Hofström

Since Specialization
Citations

This map shows the geographic impact of Camilla Hofström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camilla Hofström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camilla Hofström more than expected).

Fields of papers citing papers by Camilla Hofström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camilla Hofström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camilla Hofström. The network helps show where Camilla Hofström may publish in the future.

Co-authorship network of co-authors of Camilla Hofström

This figure shows the co-authorship network connecting the top 25 collaborators of Camilla Hofström. A scholar is included among the top collaborators of Camilla Hofström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camilla Hofström. Camilla Hofström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hofström, Camilla, et al.. (2025). Affinity maturation and optimization of CD44v6-targeting antibodies for molecular radiotherapy. Nuclear Medicine and Biology. 144-145. 109012–109012. 1 indexed citations
2.
Stenman, Adam, Ram Kumar Selvaraju, Hans Lundqvist, et al.. (2025). Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer Xenografts. Molecular Cancer Therapeutics. 24(5). 753–762. 2 indexed citations
3.
Gustafsson, Å., Ram Kumar Selvaraju, Camilla Hofström, et al.. (2025). Preclinical Validation of [ 177 Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials. Journal of Nuclear Medicine. 67(2). jnumed.125.270782–jnumed.125.270782.
4.
Sun, Rui, Fanglei Zuo, Likun Du, et al.. (2023). Design, structure and plasma binding of ancestral β-CoV scaffold antigens. Nature Communications. 14(1). 6527–6527. 2 indexed citations
5.
Berglund, H., Lova Segerström, Matthias Walle, et al.. (2023). Selection, characterization and in vivo evaluation of novel CD44v6-targeting antibodies for targeted molecular radiotherapy. Scientific Reports. 13(1). 20648–20648. 3 indexed citations
6.
Zhu, Xu, Camilla Hofström, Marika Nestor, et al.. (2023). Complementarity-determining region clustering may cause CAR-T cell dysfunction. Nature Communications. 14(1). 4732–4732. 23 indexed citations
7.
Wigren, Edvard, Elena Ossipova, Carolyn Marks, et al.. (2020). Generation and validation of recombinant antibodies to study human aminoacyl-tRNA synthetases. Journal of Biological Chemistry. 295(41). 13981–13993. 11 indexed citations
8.
Mitran, Bogdan, Mohamed Altai, Camilla Hofström, et al.. (2014). Evaluation of 99mTc-ZIGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression. Amino Acids. 47(2). 303–315. 22 indexed citations
9.
Hofström, Camilla, Mohamed Altai, Hadis Honarvar, et al.. (2013). HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [99mTc(CO)3]+-Labeled Affibody Molecules. Journal of Medicinal Chemistry. 56(12). 4966–4974. 57 indexed citations
10.
Lindberg, Hanna, Camilla Hofström, Mohamed Altai, et al.. (2012). Evaluation of a HER2-targeting affibody molecule combining an N-terminal HEHEHE-tag with a GGGC chelator for 99mTc-labelling at the C terminus. Tumor Biology. 33(3). 641–651. 20 indexed citations
11.
Orlova, Anna, Camilla Hofström, Joanna Strand, et al.. (2012). [99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours. European Journal of Nuclear Medicine and Molecular Imaging. 40(3). 439–449. 37 indexed citations
12.
Hofström, Camilla, et al.. (2011). Use of a HEHEHE Purification Tag Instead of a Hexahistidine Tag Improves Biodistribution of Affibody Molecules Site-Specifically Labeled with 99mTc, 111In, and 125I. Journal of Medicinal Chemistry. 54(11). 3817–3826. 51 indexed citations
13.
Orlova, Anna, Jennie Malmberg, Camilla Hofström, et al.. (2011). Affibody molecule 111In-DOTA-ZIGF1R:4551, a new potential probe for imaging of IGF-1R expression in malignant tumours. European Journal of Nuclear Medicine and Molecular Imaging. 38. 1 indexed citations
14.
Larsson, Karin, Camilla Hofström, Cecilia Lindskog, et al.. (2011). Novel antigen design for the generation of antibodies to G-protein-coupled receptors. Journal of Immunological Methods. 370(1-2). 14–23. 3 indexed citations
15.
Tolmachev, Vladimir, Jennie Malmberg, Camilla Hofström, et al.. (2011). Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule111In-DOTA-ZIGF1R:4551. Journal of Nuclear Medicine. 53(1). 90–97. 45 indexed citations
16.
Tolmachev, Vladimir, Camilla Hofström, Jennie Malmberg, et al.. (2010). HEHEHE-Tagged Affibody Molecule May Be Purified by IMAC, Is Conveniently Labeled with [99mTc(CO)3]+, and Shows Improved Biodistribution with Reduced Hepatic Radioactivity Accumulation. Bioconjugate Chemistry. 21(11). 2013–2022. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026